Imcheck Therapeutics SAS
About Imcheck Therapeutics
ImCheck Therapeutics is a Marseille-based, privately-held company developing next generation immuno-modulatory antibodies acting on both adaptive and innate immunity (notably gamma-delta T-cells) for the treatment of cancer and other immune related diseases.
- Focus : Laboratory
- Industry : Biotechnology
Product portfolio of Imcheck Therapeutics
Here you will find Imcheck Therapeutics SAS
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
